Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats

被引:20
|
作者
Jin Ming [1 ]
Wang Lin [1 ]
Wu Yan [1 ]
Zang Bao-xia [1 ]
Tan Li [1 ]
机构
[1] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Pharmacol, Beijing 100029, Peoples R China
关键词
hydroxysafflor yellow A; pulmonary fibrosis; pulmonary inflammation; nuclear factor-kappa B p65; alpha-smooth muscle actin; Chinese medicine; NECROSIS-FACTOR-ALPHA; ACUTE LUNG INJURY; IL-1-BETA; FIBROGENESIS; EXPRESSION; DISEASES; MODEL; MICE;
D O I
10.1007/s11655-017-2094-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
To observe the effect of hydroxysafflor yellow A (HSYA), an active ingredient of a traditional Chinese herbal medicine Carthamus tinctorius L., on lung inflflammation and pulmonary fibrosis induced by bleomycin (BLM) in rats. Animals were divided into 6 groups including normal group, model group, three HSYA groups and dexamethasone (DXM) group. Three doses of HSYA (35.6, 53.3, and 80.0 mgaEuro cent kg(-1)aEuro cent day(-1)) were intraperitoneally (i.p.) injected in rats for 3 weeks after BLM administration and DXM was used as the positive control (n=8 or 12). Arterial blood gas was assayed and morphological changes were observed. Lung mRNA expressions of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and some cytokines in lung tissue were detected by real-time polymerase chain reaction. Nuclear factor-kappa B p65 or alpha-smooth muscle actin (alpha-SMA) protein distribution in rat lung tissue was observed by immunohistochemistry. On the 7th day after BLM administration, lung tissue showed serious inflammation. Treatment with HSYA or DXM ameliorated lung inflammation. After treatment with HSYA or DXM, oxygen partial pressure (PaO2) increased (HSYA 80.0 mgaEuro cent kg(-1), P < 0.01) and CO2 partial pressure (PaCO2) decreased (HSYA 53.3, 80.0 mgaEuro cent kg(-1), P < 0.05). Moreover, the mRNA expression of TNF-alpha, IL-1 beta, and IL-6; and the number of NF-kappa B p65 positive cells was lower in HSYA 53.3 and 80.0 mgaEuro cent kg(-1) groups than those in the model group (all P < 0.05). Twenty-one days after BLM administration, HSYA or DXM treatment ameliorated fibrosis, increased PaO2 (HSYA 53.3, 80.0 mgaEuro cent kg-1, P < 0.01), and decreased PaCO2 (53.3 and 80.0 mgaEuro cent kg-1, P < 0.05). Further, the mRNA expression of TGF-beta 1, alpha-SMA, and collagen I as well as the number of alpha-SMA positive cells increased in the model group and HSYA can attenuate these changes (53.3, 80.0 mgaEuro cent kg(-1), P < 0.05). Hematoxylin and eosin and Masson's trichrome staining indicated that the fibrosis and collagen deposition were ameliorated in HSYA groups (53.3, 80.0 mgaEuro cent kg(-1), P < 0.05). HSYA could alleviate acute lung inflflammation and chronic pulmonary fibrosis induced by BLM in rats.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] Protective Effect of Eucalyptus globulus Extracts Against Bleomycin-Induced Pulmonary Fibrosis in Rats
    Brinsi, Chirine
    Abidi, Anouar
    Hosni, Karim
    Tounsi, Haifa
    Sebai, Hichem
    JOURNAL OF MEDICINAL FOOD, 2022, 25 (07) : 741 - 750
  • [22] Protective Effect of Tunisian Flaxseed Oil against Bleomycin-Induced Pulmonary Fibrosis in Rats
    Abidi, Anouar
    Kourda, Nadia
    Feki, Moncef
    Ben Khamsa, Saloua
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2020, 72 (02): : 226 - 238
  • [23] Potential Protective Effect of Agmatine on Bleomycin-Induced Pulmonary Fibrosis in Male Albino Rats
    Mehdar, Khlood Mohammed
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (03) : 305 - 317
  • [24] The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats
    Arslan, SO
    Zerin, M
    Vural, H
    Coskun, A
    JOURNAL OF PINEAL RESEARCH, 2002, 32 (01) : 21 - 25
  • [25] The effect of erythropoietin on bleomycin-induced pulmonary fibrosis in rats
    Tsavlis, Drosos
    Spandou, Evangellia
    Koliakos-Kouzi, Kokkona
    Koutsonikolas, Dimitrios
    Tzoumaka, Anna
    Simeonidou, Constantina
    Angomachalelis, Ioannis
    Bountzioukas, Solon
    CHEST, 2007, 132 (04) : 582S - 582S
  • [26] Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats
    Gong, LK
    Li, XH
    Wang, H
    Zhang, L
    Chen, FP
    Cai, Y
    Qi, XM
    Liu, LL
    Liu, YZ
    Wu, XF
    Huang, CG
    Ren, J
    JOURNAL OF ETHNOPHARMACOLOGY, 2005, 96 (03) : 537 - 544
  • [27] Protective effect of aminoguanidine in a murine model of pulmonary fibrosis induced by bleomycin
    de Rezende, MC
    Martinez, JAB
    Capelozzi, VL
    Simoes, MJ
    Beppu, OS
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2000, 14 (06) : 561 - 567
  • [28] Protective effect of cetirizine on bleomycin-induced pulmonary fibrosis in rat
    Hemmati, A. A.
    Hemmati, K. M.
    Hemmati, G. M.
    Hemmati, R. I.
    Hemmati, M. P.
    TOXICOLOGY LETTERS, 2010, 196 : S242 - S242
  • [29] Effect of FR167653 on bleomycin induced pulmonary fibrosis in rats
    Zhu, Jian-ping
    Yao, Hong-wei
    Mao, Lian-gen
    Yang, Fen-fen
    Dai, Zhen
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 377 - 378
  • [30] Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats
    Akgedik, Recep
    Akgedik, Sukran
    Karamanli, Harun
    Uysal, Sema
    Bozkurt, Bulent
    Ozol, Duygu
    Armutcu, Ferah
    Yildirim, Zeki
    INFLAMMATION, 2012, 35 (05) : 1732 - 1741